Clinical Effectiveness and Safety of Initial Combination Therapy with Corticosteroids and Rituximab in Bullous Pemphigoid: A Retrospective Cohort Study
Journal
American journal of clinical dermatology
Journal Volume
23
Journal Issue
4
Pages
571
Date Issued
2022-07
Author(s)
Abstract
Rituximab is a potential initial adjuvant therapy for bullous pemphigoid, yet clinical experience is scarce.
Subjects
PROGNOSTIC-FACTORS
EUROPEAN ACADEMY
MORTALITY
ASSOCIATION
DERMATOLOGY
INFECTIONS
MANAGEMENT
DIAGNOSIS
DEATH
RISK
SDGs
Publisher
ADIS INT LTD
Type
journal article